These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 7387270

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J, Gieburowska R, Dzierzanowska D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
    Dolna I, Ruczkowska J, Chomontowicz M.
    Przegl Lek; 1992 Oct; 49(7):213-5. PubMed ID: 1297147
    [Abstract] [Full Text] [Related]

  • 26. In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens.
    Markowitz SM, Sibilla DJ.
    Chemotherapy; 1983 Oct; 29(2):89-98. PubMed ID: 6839865
    [Abstract] [Full Text] [Related]

  • 27. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS, Frei CR.
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [Abstract] [Full Text] [Related]

  • 28. [Some biological properties of new antibiotics. II. Comparison of antibacterial activity of some selected beta-lactam and aminoglycoside antibiotics].
    Chojnowski W, Gralewicz J, Jastalska D, Morris-Rostkowsak W, Zapaśnik M.
    Acta Pol Pharm; 1977 Nov; 34(2):221-6. PubMed ID: 868553
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J, Dubreuil L, Calvet L.
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Aminoglycosides versus beta-lactams in gram-negative pneumonia.
    Collins T, Gerding DN.
    Semin Respir Infect; 1991 Sep; 6(3):136-46. PubMed ID: 1754734
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [In-vitro synergism between beta-lactam antibiotics and aminoglycoside antibiotics in Pseudomonas, Proteus and Klebsiella (proceedings)].
    Schassan HH.
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):329-37. PubMed ID: 824893
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 36. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V.
    Med Klin; 1978 Mar 24; 73(12):423-7. PubMed ID: 347234
    [Abstract] [Full Text] [Related]

  • 37. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
    Fass RJ, Barnishan J.
    Rev Infect Dis; 1980 Mar 24; 2(6):841-53. PubMed ID: 7012987
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I, Gibson G, Sawyer K, Samel C, Skalina D.
    Diagn Microbiol Infect Dis; 1988 Feb 24; 9(2):87-96. PubMed ID: 3383549
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG, Brau CJ, Cobbs CG, Dismukes WE.
    Antimicrob Agents Chemother; 1979 Dec 24; 16(6):864-8. PubMed ID: 533267
    [Abstract] [Full Text] [Related]

  • 40. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 24; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.